Fibronectin-guided migration of carcinoma collectives

Nature Communications

Volumn 8, Issue , 2017, Pages

  Gopal, Sandeep ^a   Veracini, Laurence ^a   Grall, Dominique ^a   Butori, Catherine ^c   Schaub, Sébastien ^c   Audebert, Stéphane ^c   Camoin, Luc ^a   Baudelet, Emilie ^a,d   Adwanska, Agata ^d   Beghelli De La Forest Divonne, Stéphanie ^d   Violette, Shelia M ^a   Weinreb, Paul H ^b   Rekima, Samah ^a   Ilie, Marius ^b   Sudaka, Anne ^a,d   Hofman, Paul ^b   Van Obberghen Schilling, Ellen ^a,d  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA9BETA1 INTEGRIN; ALPHAVBETA6 INTEGRIN; COLLAGEN; FIBRONECTIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; INTEGRIN;

CELLS AND CELL COMPONENTS; COLLAGEN; DATA SET; GENE EXPRESSION; PHYSIOLOGY; TUMOR;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; EPITHELIUM TUMOR; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SIGNAL TRANSDUCTION; CELL MOTION; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; INTEGRINS; MALE; MIDDLE AGED;

EID: 85010424342     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14105     Document Type: Article

References (61)

1. Cancer Genome Atlas, N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576-582 (2015).
2. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22 (2011).
3. Hynes, R. O. The extracellular matrix: not just pretty fibrils. Science 326, 1216-1219 (2009).
4. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392-401 (2006).
5. Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906 (2009).
6. Malik, R., Lelkes, P. I. & Cukierman, E. Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. Trends Biotechnol. 33, 230-236 (2015).
7. Sottile, J. & Hocking, D. C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell 13, 3546-3559 (2002).
8. Velling, T., Risteli, J., Wennerberg, K., Mosher, D. F. & Johansson, S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J. Biol. Chem. 277, 37377-37381 (2002).
9. Hynes, R. O. Fibronectins. Sci. Am. 254, 42-51 (1986).
10. Kosmehl, H. et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br. J. Cancer 81, 1071-1079 (1999).
11. Rybak, J. N., Roesli, C., Kaspar, M., Villa, A. & Neri, D. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 67, 10948-10957 (2007).
12. Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
13. Berndt, A. et al. Evidence of ED-B+ fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren). Histochem. Cell Biol. 109, 249-255 (1998).
14. Birchler, M. T. et al. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Laryngoscope 113, 1231-1237 (2003).
15. Mhawech, P., Dulguerov, P., Assaly, M., Ares, C. & Allal, A. S. EB-D fibronectin expression in squamous cell carcinoma of the head and neck. Oral Oncol. 41, 82-88 (2005).
16. Jayo, A. & Parsons, M. Imaging of cell adhesion events in 3D matrix environments. Eur. J. Cell Biol. 91, 824-833 (2012).
17. Wolf, K. et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 201, 1069-1084 (2013).
18. Bonnans, C., Chou, J. & Werb, Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786-801 (2014).
19. Fabricius, E. M. et al. Immunohistochemical analysis of integrins alphavbeta3, alphavbeta5 and alpha5beta1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. Exp. Ther. Med. 2, 9-19 (2011).
20. Naba, A. et al. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteomics 11, M111014647 (2012).
21. Veracini, L. et al. Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas. Oncotarget 6, 7570-7583 (2015).
22. Serres, E. et al. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice. Oncogene 33, 3451-3462 (2014).
23. Maubant, S. et al. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells. Blood 108, 3035-3044 (2006).
24. Munger, J. S. et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328 (1999).
25. Liao, Y. F. et al. The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J. Biol. Chem. 277, 14467-14474 (2002).
26. Roy, S. et al. The role of alpha9beta1 integrin in modulating epithelial cell behaviour. J. Oral. Pathol. Med. 40, 755-761 (2011).
27. Billings, P. C. et al. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J. Biol. Chem. 277, 28003-28009 (2002).
28. Dallas, S. L. et al. Fibronectin regulates latent transforming growth factorbeta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J. Biol. Chem. 280, 18871-18880 (2005).
29. Kinsey, R. et al. Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J. Biol. Sci. 121, 2696-2704 (2008).
30. Ramos, D. M., Chen, B., Regezi, J., Zardi, L. & Pytela, R. Tenascin-C matrix assembly in oral squamous cell carcinoma. Int. J. Cancer 75, 680-687 (1998).
31. Gibson, M. A., Kumaratilake, J. S. & Cleary, E. G. Immunohistochemical and ultrastructural localization of MP78/70 (betaig-h3) in extracellular matrix of developing and mature bovine tissues. J. Histochem. Cytochem. 45, 1683-1696 (1997).
32. Cescon, M., Gattazzo, F., Chen, P. & Bonaldo, P. Collagen VI at a glance. J. Cell Sci. 128, 3525-3531 (2015).
33. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85-89 (2012).
34. Friedl, P. & Gilmour, D. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 10, 445-457 (2009).
35. Rorth, P. Whence directionality: guidance mechanisms in solitary and collective cell migration. Dev. Cell 20, 9-18 (2011).
36. Martino, M. M. & Hubbell, J. A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 24, 4711-4721 (2010).
37. Matise, L. A. et al. Lack of transforming growth factor-beta signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res. 14, R98 (2012).
38. Malkoski, S. P. & Wang, X. J. Two sides of the story? Smad4 loss in pancreatic cancer versus head-And-neck cancer. FEBS Lett. 586, 1984-1992 (2012).
39. Bhowmick, N. A. et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851 (2004).
40. Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337 (2004).
41. Zilberberg, L. et al. Specificity of latent TGF-beta binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. J. Cell Physiol. 227, 3828-3836 (2012).
42. Hakkinen, L., Hildebrand, H. C., Berndt, A., Kosmehl, H. & Larjava, H. Immunolocalization of tenascin-C, alpha9 integrin subunit, and alphavbeta6 integrin during wound healing in human oral mucosa. J. Histochem. Cytochem. 48, 985-998 (2000).
43. Jones, J., Watt, F. M. & Speight, P. M. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J. Oral Pathol. Med. 26, 63-68 (1997).
44. Van Aarsen, L. A. et al. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-betaregulated mechanism. Cancer Res. 68, 561-570 (2008).
45. Thomas, G. J., Nystrom, M. L. & Marshall, J. F. Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J. Oral Pathol. Med. 35, 1-10 (2006).
46. Caswell, P. T. et al. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 183, 143-155 (2008).
47. Oudin, M. J. et al. Tumor cell-driven extracellular matrix remodeling drives haptotaxis during metastatic progression. Cancer Discov. 6, 516-531 (2016).
48. Balcioglu, H. E., van Hoorn, H., Donato, D. M., Schmidt, T. & Danen, E. H. The integrin expression profile modulates orientation and dynamics of force transmission at cell-matrix adhesions. J. Cell Sci. 128, 1316-1326 (2015).
49. Friedland, J. C., Lee, M. H. & Boettiger, D. Mechanically activated integrin switch controls alpha5beta1 function. Science 323, 642-644 (2009).
50. Roca-Cusachs, P., Gauthier, N. C., Del Rio, A. & Sheetz, M. P. Clustering of alpha(5)beta(1) integrins determines adhesion strength whereas alpha(v)beta(3) and talin enable mechanotransduction. Proc. Natl Acad. Sci. USA 106, 16245-16250 (2009).
51. Schiller, H. B. & Fassler, R. Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Rep. 14, 509-519 (2013).
52. Hoye, A. M., Couchman, J. R., Wewer, U. M., Fukami, K. & Yoneda, A. The newcomer in the integrin family: integrin alpha9 in biology and cancer. Adv. Biol. Regul. 52, 326-339 (2012).
53. Bozec, A. et al. Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126. Br. J. Cancer 95, 722-728 (2006).
54. Castello-Cros, R., Khan, D. R., Simons, J., Valianou, M. & Cukierman, E. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins. BMC Cancer 9, 94 (2009).
55. Cukierman, E., Pankov, R., Stevens, D. R. & Yamada, K. M. Taking cell-matrix adhesions to the third dimension. Science 294, 1708-1712 (2001).
56. Thariat, J. et al. Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02). Clin. Cancer Res. 18, 5123-5133 (2012).
57. Cseh, B. et al. Autocrine fibronectin directs matrix assembly and crosstalk between cell-matrix and cell-cell adhesion in vascular endothelial cells. J. Cell Sci. 123, 3989-3999 (2010).
58. Hofman, P. et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br. J. Cancer 98, 956-964 (2008).
59. Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 (1999).
60. Ishihama, Y. et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 4, 1265-1272 (2005).
61. Vizcaino, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226 (2014).